Intensive Insulin Therapy in Patients with Type 1 Diabetes Mellitus
作者： Sean M. Switzer , Emily G. Moser , Briana E. Rockler , Satish K. Garg
DOI: 10.1016/J.ECL.2011.12.001
关键词:
摘要: There has been a significant increase in the prevalence of type 1 diabetes mellitus and 2 past decade. The International Diabetes Foundation reported that there will be more than half-billion people with by 2030, largely emerging economies. Improved glucose control reduces microvascular macrovascular complications can accomplished intensive management. Continuous monitors allow further improvement. best way to emulate normal physiology is development an artificial pancreas. Early versions closed-loop technology may available United States next 3 5 years.
elsevier.com
sci-hub.se 参考文章(63)
JC Pickup, J Kidd, S Burmiston, N Yemane, Effectiveness of continuous subcutaneous insulin infusion in hypoglycaemia‐prone type 1 diabetes Practical Diabetes International. ,vol. 22, pp. 10- 14 ,(2005) , 10.1002/PDI.732
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette, Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes JAMA. ,vol. 295, pp. 1681- 1687 ,(2006) , 10.1001/JAMA.295.14.1681
Daniel E. Vaughn, Richard C. Yocum, Douglas B. Muchmore, Barry J. Sugarman, Andrew M. Vick, Igor P. Bilinsky, Gregory I. Frost, Accelerated pharmacokinetics and glucodynamics of prandial insulins injected with recombinant human hyaluronidase. Diabetes Technology & Therapeutics. ,vol. 11, pp. 345- 352 ,(2009) , 10.1089/DIA.2009.0013
S. Steiner, M. Hompesch, R. Pohl, P. Simms, F. Flacke, T. Mohr, A. Pfützner, L. Heinemann, A novel insulin formulation with a more rapid onset of action Diabetologia. ,vol. 51, pp. 1602- 1606 ,(2008) , 10.1007/S00125-008-1095-8
Roger S. Mazze, Ellie Strock, Sarah Borgman, David Wesley, Philip Stout, Joel Racchini, Evaluating the Accuracy, Reliability, and Clinical Applicability of Continuous Glucose Monitoring (CGM): Is CGM Ready for Real Time? Diabetes Technology & Therapeutics. ,vol. 11, pp. 11- 18 ,(2009) , 10.1089/DIA.2008.0041
K. Gokulakrishnan, K. Indulekha, S. Ganesan, S. Anuradha, V. Mohan, Adiponectin and carotid intimal medial thickness in subjects with and without glucose intolerance (CURES-82). Diabetes Technology & Therapeutics. ,vol. 12, pp. 109- 115 ,(2010) , 10.1089/DIA.2009.0100
N. H. White, H. P. Chase, S. Arslanian, W. V. Tamborlane, , Comparison of Glycemic Variability Associated With Insulin Glargine and Intermediate-Acting Insulin When Used as the Basal Component of Multiple Daily Injections for Adolescents With Type 1 Diabetes Diabetes Care. ,vol. 32, pp. 387- 393 ,(2009) , 10.2337/DC08-0800
Thomas Danne, Olga Kordonouri, Martin Holder, Holger Haberland, Sven Golembowski, Kerstin Remus, Sara Bläsig, Tanja Wadien, Susanne Zierow, Reinhard Hartmann, Andreas Thomas, Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabetes Technology & Therapeutics. ,vol. 13, pp. 1129- 1134 ,(2011) , 10.1089/DIA.2011.0084
Irl B. Hirsch, Carol A. Verderese, Interference of home blood glucose measurements and poor outcomes: a solvable problem requiring broader exposure. Diabetes Technology & Therapeutics. ,vol. 12, pp. 245- 247 ,(2010) , 10.1089/DIA.2010.0013
Satish K. Garg, Halsley K. Hoff, H.Peter Chase, The role of continuous glucose sensors in diabetes care Endocrinology and Metabolism Clinics of North America. ,vol. 33, pp. 163- 173 ,(2004) , 10.1016/J.ECL.2004.01.001